Yong Suh is a Lecturer with the Center for Biotechnology Education, where he teaches coursework on finance for biotechnology. He practices emergency medicine as a Clinical Instructor at the University of Maryland and serves as a Major in the Army National Guard. He has advised ARCH Venture Partners on early-stage healthcare investments and oversaw healthcare public equities at Farallon Capital Management. As a healthcare investment banker with Lehman Brothers and Citigroup, he completed M&A and IPO transactions for biopharmaceutical companies. He began his business career as a strategy consultant at Oliver Wyman and advised banks, insurance companies, and stock exchanges across Europe and Asia. Prior to his business career, he worked as a research fellow at the National Institutes of Health, and his published biomedical research portfolio includes comparative effectiveness research, genomics, protein biochemistry, and calcium signal transduction. Dr. Suh received his MD from Johns Hopkins and completed a residency in emergency medicine at the University of Chicago. Prior to his medical training, he completed both an MBA and an MSc by Research in Pharmacology at the University of Oxford, where he studied as a Marshall Scholar. He is an elected Term Member of the Council on Foreign Relations.